Oxford Drug Design shortlisted for CogX 2020 award for ‘Best AI Product in Health’

Oxford Drug Design is proud to have been shortlisted for this year’s CogX award for ‘Best AI product in health’. CogX is an annual festival of AI and emerging tech that brings together leaders, entrepreneurs, and policy makers from all sectors to address the problems of the future. CognitionX aims to educate and promote AI […]

Oxford Drug Design attends the 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery

Prof. Paul Finn presented on a major cause of failure of antibacterial drug discovery projects, failure to accumulate sufficiently at the site of action to obtain an antibacterial effect, at the 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery. Prof. Finn reviews attempts to address this issue through greater understanding the structural basis for penetration and the […]

Oxford Drug Design attends the Theory and Modelling in Chemical Sciences Annual Symposium

Dr Paul Finn attended the theory and modelling chemical sciences annual symposium in Bristol. The theory and modelling in chemical sciences centre for doctoral training comprises of academics form Oxford, Southampton and Bristol. Its aim is advance the theory and computer modelling methods as applied in chemical and allied sciences. TMCS has a number of partner organizations, including […]

Oxford Drug Design attends CCG’s European User Group Meeting and Conference

Dr. Jerome Wicker recently presented our latest work on the effect of charge and conformation on enrichment of DUD-E targets. Using both our own in-house ElectroShape compound descriptors and other commercially available descriptors, Jerome demonstrated how different conformer generation methods and partial charge models can improve the ranking of actives and decoys for targets in […]

Prof. Graham Richards awarded the Richard J. Bolte Sr. Award for Supporting Industries

Oxford Drug Design Chairman and Co-founder Prof. W. Graham Richards has been awarded the Richard J. Bolte Sr. Award for Supporting Industries. This award honours those who provide products or services vital to the continuing growth and development of the chemical and molecular sciences community. Graham has been recognised for his pioneering work in the […]

Oxford Drug Design attends Medicines Discovery Catapult’s Antimicrobial Resistance Workshop

Dr. Michael Charlton presented a review of literature analyses of the physical properties of antibacterial compounds. This included an emphasis on our own work, extending past studies to include a much greater number of antibacterial compounds, which shows that the properties of antibacterials are not significantly different from non-antibacterial compounds. Michael touched on how we are extending […]